Europe Telemedicine Market Size and Share

Europe Telemedicine Market (2026 - 2031)
Image 漏 麻豆视频. Reuse requires attribution under CC BY 4.0.
View Global Report

Europe Telemedicine Market Analysis by 麻豆视频

The Europe Telemedicine Market size was valued at USD 48.72 billion in 2025 and is estimated to grow from USD 57.88 billion in 2026 to reach USD 137.03 billion by 2031, at a CAGR of 18.81% during the forecast period (2026-2031).

Structural growth is anchored in the European Health Data Space Regulation, which requires cross-border health-data exchange and favors vendors with proven interoperability. The removal of Germany鈥檚 30% video-consult cap in December 2023 triggered a 40% teleconsultation surge within six months, underscoring how reimbursement rules unleash latent demand. Cloud deployments are accelerating as 5G now covers 89% of EU residents, allowing mid-sized hospitals to avoid large upfront IT investments. Legacy PSTN telecare gear faces forced retirement ahead of the United Kingdom鈥檚 January 2027 switch-off, opening a USD 1.02 billion replacement cycle. Meanwhile, cybersecurity remains a top risk as 54% of European providers reported ransomware attacks in 2024.

Key Report Takeaways

  • By telemedicine type, telehospitals led with 45.56% revenue share in 2025, while telehomes are projected to expand at a 19.25% CAGR through 2031. 
  • By component, services accounted for 65.53% of the Europe telemedicine market size in 2025, whereas products are advancing at a 20.85% CAGR to 2031. 
  • By mode of delivery, on-premise systems held 57.63% share in 2025 and cloud solutions are growing at a 19.87% CAGR through 2031. 
  • By end-user, hospitals captured 52.13% share of the Europe telemedicine market size in 2025; home-care settings post the highest 22.7% CAGR over the period. 
  • By geography, Germany commanded 25.13% market share in 2025, while Spain records the fastest 19.81% CAGR to 2031.

Note: Market size and forecast figures in this report are generated using 麻豆视频鈥檚 proprietary estimation framework, updated with the latest available data and insights as of January 2026.

Segment Analysis

By Telemedicine Type: Hospitals Anchor, Homes Accelerate

Telehospitals accounted for 45.56% of the Europe telemedicine market share in 2025, with ICU and radiology workflows justifying dedicated cameras and secure networks. Remote intensivist oversight lowered hospital mortality by 15% that year. Telehomes, though smaller, will outpace the Europe telemedicine market at a 19.25% CAGR to 2031 as wearables support continuous chronic-care surveillance. National mandates to cut bed use, such as France鈥檚 EUR 400 million home-monitoring fund, accelerate adoption[2]French Ministry of Health, 鈥淪茅gur du num茅rique en sant茅,鈥 solidarites-sante.gouv.fr .

Hospital-at-home pilots in 42 facilities already show equal outcomes at 30% lower cost, fuelling policy momentum. mHealth apps leverage smartphone ubiquity yet still hunt viable revenue models. The NHS App hit 35 million users in 2024, giving governments scale but constraining innovation. Norway鈥檚 e-consult sick-leave feature saved EUR 25 million in productivity. Convergence across settings will blur categories, supporting diversified growth in the Europe telemedicine market.

Europe Telemedicine Market: Market Share by Telemedicine Type
Image 漏 麻豆视频. Reuse requires attribution under CC BY 4.0.
Europe Telemedicine Market: Market Share by Telemedicine Type

By Component: Services Dominate, Products Surge

Services held 65.53% of the Europe telemedicine market size in 2025, led by teleradiology, telepsychiatry, and tele-ICU consults. AI image assistance cut radiologist time per study by nearly half in Norway. Telepsychiatry volumes remain elevated, with eMeistring delivering CBT at 60% of traditional costs.

Products - hardware, software, and connectivity - will grow at a 20.85% CAGR as the PSTN sunset drives device refreshes. Remote-monitoring kits and AI-stethoscopes integrate software subscriptions at EUR 50-150 per clinician monthly. Smartphone cameras now meet dermatology resolution standards, reducing hardware prices by 70%. Integration of predictive analytics into devices differentiates offerings and underpins long-term expansion of the Europe telemedicine market.

By Mode of Delivery: Cloud Gains on Premises

On-premise deployments owned 57.63% share in 2025, favored by large systems complying with data-residency mandates such as Germany鈥檚 BSI rule. However, cloud solutions will rise at 19.87% CAGR as mid-size providers pursue elasticity and lower capex. Doctolib processed 90 million visits on a French-hosted cloud in 2024, validating scale economics.

Hybrid models retain data locally while streaming video and analytics from the cloud, balancing compliance and performance. EHDS interoperability favors shared cloud connectors over bespoke interface builds, improving time-to-market. Edge servers in 23 hospitals already run AI inference with sub-100 ms latency, illustrating the architecture likely to dominate the Europe telemedicine market.

Europe Telemedicine Market: Market Share by Mode of Delivery
Image 漏 麻豆视频. Reuse requires attribution under CC BY 4.0.

By End-User: Hospitals Lead, Homes Outpace

Hospitals commanded 52.13% share of the Europe telemedicine market size in 2025, leveraging economies across multiple departments. NHS tariffs now reward 30% virtual outpatients by 2028. Yet home-care settings will grow fastest at 22.7% CAGR, enabled by remote cardiac, pulmonary, and diabetic monitoring that cut 30-day readmissions by 25%.

Payers reward enrollment, offering 5-10% premium discounts, and Spain commits EUR 1.5 billion for home infrastructure. Decentralized clinical trials share technology stacks, spurring vendor scale. Hospital-at-home schemes demonstrate inpatient-equivalent outcomes at 30% lower cost, ensuring sustained penetration of home models within the Europe telemedicine market.

Geography Analysis

Germany led the Europe telemedicine market with 25.13% share in 2025 thanks to DiGA reimbursement, e-prescriptions, and post-cap teleconsult surges. Strict data-residency rules raise hosting costs but sustain local IT demand. The United Kingdom ranks second, supported by 35 million NHS App users and upgraded digital infrastructure, yet faces PSTN-hardware migration risks. France benefits from Doctolib network effects that entrench user loyalty.

Spain is poised for 19.81% CAGR, double the bloc average, as teleconsults already exceed one-quarter of visits and EUR 1.5 billion funds digital integration. Italy鈥檚 PNRR sets aside EUR 1.7 billion for rural digital health, promising catch-up momentum. Nordic nations maintain highest maturity scores, while Eastern Europe lags on funding and reimbursement. Estonia鈥檚 near-universal e-records showcase scalable models for small states. Denmark鈥檚 outcome-based tenders demand 15% readmission cuts, shaping procurement.

EHDS will force convergence by 2029, yet linguistic differences still depress satisfaction by 22% in cross-language consults, limiting cross-border telemedicine to bilingual regions. Overall, geographic disparities present both risk and opportunity within the Europe telemedicine market.

Regulatory Landscape

Telemedicine regulation in Europe is being shaped by the European Health Data Space (EHDS) framework and national reimbursement and licensing rules. Regulation (EU) 2025/327 entered into force in March 2025, setting an EU-wide direction for cross-border electronic health data movement and raising the bar for interoperability and secure exchange in workflows that underpin teleconsults, remote monitoring, and e-prescriptions.

Implementation governance advanced in April 2026 with Commission Implementing Regulation (EU) 2026/771, which establishes the EHDS Board to coordinate application and technical specifications. The EHDS timeline introduces concrete compliance pressure points for providers and vendors, including mandatory MyHealth@EU participation by 2029 for Member States and conformance expectations for EHR systems around interoperability, logging, and security, alongside continuing GDPR enforcement that elevates data protection and breach response requirements in telemedicine operations.

Competitive Landscape

No company commands a significant share, leaving the market moderately fragmented, yet network effects accelerate consolidation. Doctolib鈥檚 90 million consults exhibit winner-take-most dynamics. Large med-techs - Philips, Medtronic, and IBM - bundle telemedicine with existing devices, locking clients into multi-year contracts[3]Koninklijke Philips N.V., 鈥淚nvestor Presentation 2025,鈥 philips.com. Pure-plays struggle as fee parity erodes margins; 18 exited since 2023.

Specialty niches such as rare diseases and mental health offer white-space growth. AI-triage patents rose 35% year-over-year, signaling hardware-software convergence. EHDS will commoditize video functions, shifting competition toward predictive analytics and outcome contracts. Persistent ransomware risks, with 71% of breaches disrupting care, elevate security as a differentiator. Overall, competitive intensity remains high as the Europe telemedicine market evolves toward platform ecosystems.

Europe Telemedicine Industry Leaders

  1. IBM Corporation

  2. Koninklijke Philips NV

  3. Medtronic Plc

  4. Veradigm LLC

  5. AMD Global Telemedicine

  6. *Disclaimer: Major Players sorted in no particular order
Europe Telemedicine Market
Image 漏 麻豆视频. Reuse requires attribution under CC BY 4.0.

Market Opportunities and Future Outlook

EHDS implementation creates near-term whitespace for vendors that can operationalize interoperability, identity, consent, audit logging, and secure exchange across hospital and home-care workflows. The shift from voluntary to mandated cross-border infrastructure (MyHealth@EU by 2029) and the rollout of European digital testing environments for EHR conformance push procurement toward platforms that can document compliance with essential requirements. At the same time, fragmentation in national definitions, liability, and reimbursement sustains demand for compliance-led service layers, including multi-country billing logic, localization, and contract-ready data processing models.

Hospital-at-home and remote monitoring programs provide a concrete demand pull for acute-grade virtual care stacks, including multi-parameter wearables, tele-ICU oversight, and integrated triage into EHR nodes. Pan-regional coordination efforts also broaden the pipeline of deployable digital health models beyond early adopter markets, highlighted by the June 2026 WHO/Europe Memorandum of Understanding with Healthcare Denmark to advance digital health, data, and AI cooperation across the WHO European Region through June 2031. This reinforces the role of shared standards and transferable implementation playbooks for scaling telemedicine capabilities across diverse health systems.

Recent Industry Developments

  • May 2026: Philips announced it was selected as part of a consortium (including Cuviva and Vingmed) under an eight-year agreement with Region Stockholm to support hospital-at-home care for up to 15,000 patients annually. The award strengthens large-scale virtual acute care deployment in Europe and increases demand for integrated remote monitoring, clinician workflows, and secure data exchange that can operate across care settings.
  • February 2026: Medtronic began the EMEA commercial launch of the MiniMed Go Smart MDI system with the Simplera sensor in Europe, linking diabetes management with more connected care pathways. The rollout supports broader adoption of telemedicine-enabled chronic care by embedding data-driven decision support into routine patient management outside the clinic.
  • March 2025: UniDoc Health Corp. completed the purchase of AMD Global Telemedicine's AGNES Connect software and related intellectual property. The transaction consolidates telehealth software assets under a single owner and can accelerate roadmap investment in interoperability and platform integration for enterprise telemedicine deployments.

Table of Contents for Europe Telemedicine Industry Report

1. Introduction

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope of the Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing remote patient monitoring
    • 4.2.2 Growing burden of chronic diseases
    • 4.2.3 Government reimbursement reforms for digital health
    • 4.2.4 Expansion of 5G & fibre connectivity
    • 4.2.5 Cross-border value-based hospital procurement
    • 4.2.6 Pan-EU AI-triage APIs integrated into national EHR nodes
  • 4.3 Market Restraints
    • 4.3.1 Legal & reimbursement complexity
    • 4.3.2 GDPR-driven data-privacy concerns
    • 4.3.3 PSTN switch-off risking legacy telecare hardware
    • 4.3.4 Clinician digital-fatigue lowering post-COVID retention
  • 4.4 Regulatory Landscape
  • 4.5 Technological Outlook
  • 4.6 Porter's Five Forces
    • 4.6.1 Bargaining Power of Suppliers
    • 4.6.2 Bargaining Power of Buyers
    • 4.6.3 Threat of New Entrants
    • 4.6.4 Threat of Substitutes
    • 4.6.5 Competitive Rivalry

5. Market Size & Growth Forecasts (Value, USD)

  • 5.1 By Telemedicine Type
    • 5.1.1 Telehospitals
    • 5.1.2 Telehomes
    • 5.1.3 mHealth (Mobile Health)
  • 5.2 By Component
    • 5.2.1 Products
    • 5.2.1.1 Hardware
    • 5.2.1.2 Software
    • 5.2.1.3 Other Products
    • 5.2.2 Services
    • 5.2.2.1 Telepathology
    • 5.2.2.2 Telecardiology
    • 5.2.2.3 Teleradiology
    • 5.2.2.4 Teledermatology
    • 5.2.2.5 Telepsychiatry
    • 5.2.2.6 Tele-ICU
  • 5.3 By Mode of Delivery
    • 5.3.1 On-premise Delivery
    • 5.3.2 Cloud-based Delivery
  • 5.4 By End-user
    • 5.4.1 Hospitals & Clinics
    • 5.4.2 Home-care Settings
    • 5.4.3 Payers & Insurers
    • 5.4.4 Others (NGOs, Pharma-sponsored Programs)
  • 5.5 By Country
    • 5.5.1 Germany
    • 5.5.2 United Kingdom
    • 5.5.3 France
    • 5.5.4 Italy
    • 5.5.5 Spain
    • 5.5.6 Rest of Europe

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Market Share Analysis
  • 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share, Products & Services, Recent Developments)
    • 6.3.1 Aerotel Medical Systems Ltd.
    • 6.3.2 AMD Global Telemedicine
    • 6.3.3 Babylon Health
    • 6.3.4 Banner Health (tele-ICU EU JV)
    • 6.3.5 Chiptech Europe
    • 6.3.6 Comarch SA
    • 6.3.7 Dignio AS
    • 6.3.8 Doctolib SE
    • 6.3.9 Essence Group
    • 6.3.10 GlobalMedia Group
    • 6.3.11 Huma Therapeutics
    • 6.3.12 IBM Corporation
    • 6.3.13 Koninklijke Philips N.V.
    • 6.3.14 KRY International AB
    • 6.3.15 Legrand Care
    • 6.3.16 Luscii Healthtech
    • 6.3.17 Medtronic plc
    • 6.3.18 OTH.IO
    • 6.3.19 Resideo Technologies Inc.
    • 6.3.20 SHL Telemedicine
    • 6.3.21 Teladoc Health Inc.
    • 6.3.22 Tunstall Healthcare
    • 6.3.23 Veradigm LLC

7. Market Opportunities & Future Outlook

  • 7.1 White-space & Unmet-need Assessment

Research Methodology Framework and Report Scope

Market Definition and Coverage

For this study, the European telemedicine market means paid remote clinical services and the enabling products used to assess, consult, monitor, and treat patients through telecom and digital channels across Europe.

Scope exclusions: Purely in-person care delivery and healthcare IT that does not support remote care workflows are excluded from this sizing.

Segmentation Overview

  • By Telemedicine Type
    • Telehospitals
    • Telehomes
    • mHealth (Mobile Health)
  • By Component
    • Products
      • Hardware
      • Software
      • Other Products
    • Services
      • Telepathology
      • Telecardiology
      • Teleradiology
      • Teledermatology
      • Telepsychiatry
      • Tele-ICU
  • By Mode of Delivery
    • On-premise Delivery
    • Cloud-based Delivery
  • By End-user
    • Hospitals & Clinics
    • Home-care Settings
    • Payers & Insurers
    • Others (NGOs, Pharma-sponsored Programs)
  • By Country
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe

Data Sources, Market Sizing, and Validation

Desk Research

Desk work starts with building a consistent view of demand, supply, and policy signals across Europe, since telemedicine adoption can accelerate after reimbursement or care pathway changes. We review public health and digital health publications from sources such as the World Health Organization (Europe), the European Commission, and OECD health statistics, and we also check guidance from national health ministries and regulators in larger countries.

To keep assumptions realistic, we cross-check usage and infrastructure indicators using sources such as Eurostat, peer-reviewed journals on virtual care outcomes, and trade association updates on digital health and remote monitoring. Company filings, investor presentations, and reputable press are used to understand offering mix, pricing direction, and where revenue is being recognized by geography. Select paid subscriptions are used only to speed up company financials and news screening, and to spot patent activity tied to telemedicine platforms and devices. These references are illustrative, and many other public sources were also used for data collection, validation, and clarification.

Primary Interviews and Surveys

Primary discussions are used to test what remote care is actually being paid for, and how reimbursement, procurement, and clinical protocols shape volumes and pricing. We spoke with a mix of provider-side leaders, digital health program owners, payer-facing stakeholders, and solution delivery teams across major European markets. After the initial conversations, we ran follow-up checks when numbers looked inconsistent, especially around what was counted as a telemedicine service versus supporting enabling products.

Distribution of primary research fieldwork respondents

Company typeRespondent positionRegion
Top tier: 31% CXOs: 19%APAC: 41%
Mid tier: 48% Functional/Unit leaders: 40%EMEA: 32%
Smaller Players: 21% Managers: 41%Americas: 27%

Market-Sizing & Forecasting

The model is built using a top-down approach where the addressable care delivered remotely is reconstructed from country-level healthcare activity signals, payer reimbursement direction, and the share of visits shifting to virtual channels. Once that demand pool is shaped, it is converted into revenue using typical service mix and pricing ranges that were checked during interviews.

We then corroborate the totals with selective bottom-up approximations, such as sampling provider network volumes, checking platform and device revenue splits, and using sampled ASP multiplied by adoption volumes in a few anchor countries, before the regional roll-up is finalized. Key inputs include teleconsultation utilization trends, remote patient monitoring penetration by chronic conditions, digital health reimbursement coverage, cloud versus on-premise deployment preference, and hospital and home-care staffing constraints that push virtual care usage. Forecasts are produced using scenario analysis, since policy timelines and reimbursement expansion can move faster or slower, and the scenario weights are adjusted based on expert consensus. Where direct country metrics are missing, proxies like comparable-country adoption curves and publicly reported virtual care program coverage are applied, then reviewed again with respondents for reasonableness.

Data Validation & Update Cycle

Results are validated through multiple checks, including comparing implied revenue per virtual encounter against reported pricing ranges, and verifying growth rates against independent signals such as reimbursement expansion and provider rollouts. Outliers are investigated by revisiting the input assumptions, rechecking currency timing, and confirming whether a metric represents booked revenue or delivered services. Before sign-off, the model and the written assumptions go through an internal review so inconsistencies are caught early.

The report is refreshed on an annual cycle, and interim updates are triggered when material policy changes, major reimbursement decisions, or large adoption shocks occur in key European markets. Right before delivery, we run a final pass to ensure the latest publicly available indicators and confirmed interview feedback are reflected.

麻豆视频's European Telemedicine Market Market Estimate Compared With Other Published Estimates

It is common to see different market sizes for European telemedicine because publishers do not always count the same revenue streams, and their base years and currency handling can differ. The spread usually comes from how telehealth is defined, how quickly pricing is assumed to move, and whether forecasts reflect a base case or a more aggressive adoption path.

Some estimates group broader telehealth activity and keep the scope closer to component-only revenue or a narrower function list. In the 麻豆视频 build, we count telemedicine types such as telehospitals, telehomes, and mHealth across both products and services, and we keep the geography consistent across major countries and the rest of Europe with interview-backed mix assumptions.

Benchmark comparison

SourceMarket SizeGaps in Research Methodology
麻豆视频 USD 48.72 B (2025)
Global Consultancy A USD 24.76 B (2025)Uses a combined telehealth and telemedicine view with a different segmentation lens and base-year setup, which can undercount specialty telemedicine services and related product revenue when only selected functions or components are emphasized.
Industry Publisher B USD 17.71 B (2024)Anchors the market on a 2024 revenue base and focuses on telehealth by broad components (hardware, software, services), which can shift totals if service definitions, included care settings, and currency year timing differ.

Taken together, the comparison shows that scope and year alignment explain most of the difference, more than simple math errors. When the included care settings, service types, and revenue recognition rules are spelled out clearly and then checked with a few independent demand signals, the final number becomes easier to trace and repeat.

Key Questions Answered in the Report

How large is the Europe telemedicine market in 2026?

It stands at USD 57.88 billion with an 18.81% CAGR outlook to 2031.

Which segment grows fastest by 2031?

Home-care settings lead with a 22.7% CAGR as aging populations adopt remote monitoring.

Why is Spain the quickest-growing geography?

High teleconsultation penetration plus EUR 1.5 billion government funding drive a 19.81% CAGR.

What triggers the product-replacement boom?

The January 2027 U.K. PSTN switch-off requires 1.8 million legacy telecare devices to migrate to IP.

How do EU rules shape data exchange?

Regulation EU 2025/327 mandates AI-triage APIs in all national EHR nodes by 2029, forcing interoperability.

What cybersecurity risks influence adoption?

Ransomware hit 54% of European providers in 2024, prompting 72-hour breach reporting under GDPR.

Page last updated on: